cilostazol has been researched along with Complications of Diabetes Mellitus in 15 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cilostazol is useful for the prevention of the recurrence of vascular events in patients with lacunar infarction, and is probably effective in high-risk patients with diabetes and/or hypertension." | 5.13 | Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study. ( Fukuuchi, Y; Gotoh, F; Hirai, S; Itoh, E; Matsuda, T; Nishimaru, K; Ohashi, Y; Otomo, E; Sawada, T; Shinohara, Y; Terashi, A; Tohgi, H; Yamaguchi, T, 2008) |
| "Diabetic and non-diabetic patients with intermittent claudication respond favourably to cilostazol, with no significant difference in their overall response." | 5.10 | Cilostazol treatment of claudication in diabetic patients. ( Cariski, AT; Hittel, N; Rendell, M; Zhang, P, 2002) |
| "The aim of this study was to evaluate the effect of a three-month cilostazol treatment on the health-related quality of life and on the lower-limb functional capacity in diabetic (DM) and non-diabetic patients (NDM) with intermittent claudication in the clinical practice." | 3.96 | Cilostazol improves the quality of life and lower-limb functional capacity also in diabetic patients ( Farkas, K; Járai, Z; Kolossváry, E, 2020) |
| "The key areas of treatment focus on smoking cessation, exercise rehabilitation, with supervised therapy if possible, cardiovascular risk prevention with antiplatelet drugs, statins and angiotensin converting enzymes, and correction of atherosclerotic risk factors with well-defined targets (LDL less than 1g/L, HDL greater than 0." | 2.45 | [Peripheral arterial disease with lower limb claudication: Medical treatment]. ( Bui, HT; Hadj Henni, A; Journet, J; Long, A, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Farkas, K | 1 |
| Kolossváry, E | 1 |
| Járai, Z | 1 |
| Mohamed, MZ | 1 |
| Hafez, HM | 1 |
| Zenhom, NM | 1 |
| Mohammed, HH | 1 |
| Lee, SW | 2 |
| Lee, JY | 2 |
| Ahn, JM | 1 |
| Park, DW | 2 |
| Han, S | 1 |
| Park, YK | 1 |
| Lee, WS | 1 |
| Jang, JY | 1 |
| Kwon, CH | 1 |
| Park, GM | 1 |
| Cho, YR | 1 |
| Kim, WJ | 2 |
| Kang, SJ | 1 |
| Kim, YH | 2 |
| Lee, CW | 2 |
| Kim, JJ | 1 |
| Park, SW | 2 |
| Park, SJ | 2 |
| Shinohara, Y | 2 |
| Gotoh, F | 1 |
| Tohgi, H | 1 |
| Hirai, S | 1 |
| Terashi, A | 1 |
| Fukuuchi, Y | 1 |
| Otomo, E | 1 |
| Itoh, E | 1 |
| Matsuda, T | 1 |
| Sawada, T | 1 |
| Yamaguchi, T | 1 |
| Nishimaru, K | 1 |
| Ohashi, Y | 1 |
| Long, A | 1 |
| Bui, HT | 1 |
| Journet, J | 1 |
| Hadj Henni, A | 1 |
| Chun, KJ | 1 |
| Kim, HS | 1 |
| Yun, SC | 1 |
| Hong, MK | 1 |
| Rhee, KS | 1 |
| Chae, JK | 1 |
| Ko, JK | 1 |
| Park, JH | 1 |
| Lee, JH | 1 |
| Choi, SW | 1 |
| Jeong, JO | 1 |
| Seong, IW | 1 |
| Jon, S | 1 |
| Cho, YH | 1 |
| Lee, NH | 1 |
| Kim, JH | 2 |
| Ferreiro, JL | 1 |
| Cequier, AR | 1 |
| Angiolillo, DJ | 1 |
| Rendell, M | 1 |
| Cariski, AT | 1 |
| Hittel, N | 1 |
| Zhang, P | 1 |
| Miller, MS | 1 |
| Ahn, Y | 1 |
| Jeong, MH | 1 |
| Jeong, JW | 1 |
| Kim, KH | 1 |
| Ahn, TH | 1 |
| Kang, WC | 1 |
| Park, CG | 1 |
| Chae, IH | 1 |
| Nam, CW | 1 |
| Hur, SH | 1 |
| Bae, JH | 1 |
| Kim, KY | 1 |
| Oh, SK | 1 |
| Nomura, S | 1 |
| Imamura, A | 1 |
| Okuno, M | 1 |
| Kamiyama, Y | 1 |
| Fujimura, Y | 1 |
| Ikeda, Y | 1 |
| Fukuhara, S | 1 |
| Hiatt, WR | 1 |
| Nehler, MR | 1 |
4 reviews available for cilostazol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
[Peripheral arterial disease with lower limb claudication: Medical treatment].
Topics: Aged; Antihypertensive Agents; Arteriosclerosis; Cilostazol; Comorbidity; Diabetes Complications; Dr | 2009 |
[Japanese Guidelines for the Management of Stroke 2009 : important revised points necessary for the neurologist].
Topics: Aspirin; Atorvastatin; Cilostazol; Diabetes Complications; Dyslipidemias; Evidence-Based Medicine; H | 2010 |
Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromes.
Topics: Acute Coronary Syndrome; Administration, Oral; Aspirin; Cilostazol; Clopidogrel; Diabetes Complicati | 2010 |
Peripheral arterial disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cilostazol; Diabetes Complications; Diabetes Mellitus; Dis | 2001 |
5 trials available for cilostazol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials).
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Diabetes Compl | 2013 |
Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
Topics: Aged; Brain Ischemia; Cerebral Infarction; Cilostazol; Diabetes Complications; Double-Blind Method; | 2008 |
Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cilostazol; Clopidogrel; Coronary Restenosis; Diabete | 2010 |
Cilostazol treatment of claudication in diabetic patients.
Topics: Adult; Cilostazol; Diabetes Complications; Diabetes Mellitus; Double-Blind Method; Female; Humans; I | 2002 |
Randomized comparison of cilostazol vs clopidogrel after drug-eluting stenting in diabetic patients--clilostazol for diabetic patients in drug-eluting stent (CIDES) trial.
Topics: Aged; Aspirin; Cilostazol; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Coronary Rest | 2008 |
6 other studies available for cilostazol and Complications of Diabetes Mellitus
| Article | Year |
|---|---|
Cilostazol improves the quality of life and lower-limb functional capacity also in diabetic patients
Topics: Aged; Case-Control Studies; Cilostazol; Diabetes Complications; Diabetes Mellitus; Female; Humans; I | 2020 |
Cilostazol alleviates streptozotocin-induced testicular injury in rats via PI3K/Akt pathway.
Topics: Animals; Cilostazol; Diabetes Complications; Diabetes Mellitus, Experimental; Glutathione; Heme Oxyg | 2018 |
Peripheral artery disease. Heart health for your legs.
Topics: Angioplasty, Balloon; Atherosclerosis; Cilostazol; Diabetes Complications; Exercise; Fibrinolytic Ag | 2014 |
Pharmacotherapy as adjunctive treatment for serious foot wounds in the patient with diabetes: a case study.
Topics: Administration, Topical; Anti-Bacterial Agents; Chronic Disease; Cilostazol; Combined Modality Thera | 2003 |
Drugs for intermittent claudication.
Topics: Cilostazol; Diabetes Complications; Exercise Therapy; Female; Ginkgo biloba; Humans; Hyperlipidemias | 2004 |
Platelet-derived microparticles in patients with arteriosclerosis obliterans: enhancement of high shear-induced microparticle generation by cytokines.
Topics: Aged; Arteriosclerosis Obliterans; Biomarkers; Blood Platelets; Blood Vessel Prosthesis Implantation | 2000 |